These findings indicate that IFNγ, primarily produced by Th1 T cells, drives neuroinflammation, demyelination, and neurodegeneration in a rodent model of MSA, highlighting IFNγ as a potential therapeutic target for future investigation in MSA. The gene discussed is IFNG; the disease is multiple system atrophy.